Influence
September 9, 2021

Regenstrief research scientist: Possibility of COVID, flu “twindemic” very real

Regenstrief Institute Director of Public Health Informatics Brian Dixon, PhD, MPA, is one of many public health experts who are concerned about severe COVID-19 infections stacking on top of regular flu hospitalizations.  

“The possibility of a ‘twindemic’ is very real, especially this year,” he said. Last year there were very few flu cases, but experts attribute that to mask mandates, social distancing and other restrictions. The situation is much different this year. Dr. Dixon believes the U.S. will have at least a normal flu season, if not a bad one.  

“With our hospital system already overburdened from COVID-19, there is a real concern about flu coming in this fall, as it does every year, and putting additional strain on the healthcare system,” Dr. Dixon said. 

He and other experts are recommending people wear a mask and get vaccines for both flu and COVID-19 if they are eligible.  

 Read the Business Insider article featuring Dr. Dixon

Related News

image showing two people connecting through a kidney

Regenstrief Institute awarded KidneyX prize to advance living kidney donation

LIVINGkidney digital tool recognized in national HHS competition focused on reducing barriers for living kidney donors and transplant patients  Regenstrief

LOINC® version 2.83 enhances global health data exchange through new terminology and implementation improvements

Release expands terminology for drug and toxicology testing, microbiology, public health reporting and allergy information Regenstrief Institute has released

Matt Bair, MD

Regenstrief researcher appointed deputy chief of research and development service at Richard L. Roudebush VA Medical Center

Matthew Bair, M.D., M.S., a research scientist at the Regenstrief Institute and professor of medicine at the Indiana University

Arthur Owora, PhD

Machine learning tool improves pediatricians’ ability to identify children at risk for persistent asthma 

Pilot randomized trial finds EHR-integrated decision support improved clinicians’ prediction of school-age asthma  A machine learning tool that analyzes